Skip to main content
. 2014 Jan 15;9(1):e85371. doi: 10.1371/journal.pone.0085371

Table 2. Summary of patients with neutralizing activity against HIV-1JR-FL and/or HIV-2/HIV-1 7312-C1.

Patient ID # IC50 * (μg/mL) IC50?
Virus Virus
JR-FL VSV-g 7312-C1 7312-C1C 7312A
9 34.1 > 200 < 100 < 100 < 100
10 56.0 > 200 < 100 < 100 < 100
11 125.0 > 200 < 100 < 100 < 100
12 42.9 > 200 108 < 100 < 100
18 127.3 > 200 116 < 100 < 100
26 > 200 > 200 109 < 100 < 100
32 65.5 > 200 < 100 < 100 < 100
35 41.5 > 200 < 100 < 100 < 100
41 38.7 > 200 < 100 < 100 < 100
42 17.5 > 200 < 100 < 100 < 100
48 3.0 > 200 125 < 100 < 100
50 77.8 > 200 < 100 < 100 < 100

Polyclonal inhibitory concentration of purified IgG fractions

? Reciprocal dilution factor of serum samples